CN Patent

CN113645966A — 口服吸收高的t4甲状腺激素溶液的给药方案

Assigned to Altergon SA · Expires 2021-11-12 · 5y expired

What this patent protects

描述T4甲状腺激素的新给药方案，其特征在于，使用所述激素的无酒精、水‑甘油溶液，在距最近一餐的短时间内给药，即在小于30分钟内，通常15分钟至小于30分钟之间给药。

USPTO Abstract

描述T4甲状腺激素的新给药方案，其特征在于，使用所述激素的无酒精、水‑甘油溶液，在距最近一餐的短时间内给药，即在小于30分钟内，通常15分钟至小于30分钟之间给药。

Drugs covered by this patent

Patent Metadata

Patent number
CN113645966A
Jurisdiction
CN
Classification
—
Expires
2021-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Altergon SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.